A new institute at Penn’s Basser Center will use artificial intelligence and biomarkers to intercept hereditary cancers at their earliest stages, before they become disease. The idea behind the gift is unusual enough to need its own word. Most cancer philanthropy funds treatment, the long campaign that begins once a tumour has announced itself. Jon […]

This story continues at The Next Web